MedPath

‘Klaibya’ me Trikantakadi churna aur Vanga bhasma ka prayog

Phase 2/3
Completed
Conditions
Male erectile dysfunction, unspecified,
Registration Number
CTRI/2019/05/019108
Lead Sponsor
National Institute of Ayurveda
Brief Summary

AIMS AND OBJECTIVES:

To evaluate the clinical efficacy of *Trikantakadi Churna* and *Vanga Bhasma* in the management of *Klaibya* (Erectyle dysfunction) and Reduction in Subjective parameters i.e. *Nayati*/*Aharshanam* (**Loss of sexual desire**), *Dhvjanucchraya (***Lack of Penile Erection***), Lingashaithilya / mlalashishna* **(Lack of penile rigidity),** *Chirat praseka / badhnati shukra /* *nirveejam* **(delayed / retarded ejaculation),** *Apraharsha* **(Lack of orgasm),** *Maithune svasakrucchrata* **(Difficulty in breathing during sexual act),** *swinnagatra* **(perspiration during sexual act),** *Moghasankalpa* **(Lack of confidence),** *Moghachesta* **(Incompleteness of sexual act),** *Pandu varna* **(Pallor complexion),** *sudurbala* **(Weakness),** *alpa prana* **(lack of enthusiasm),** *vasti/vrushna/medhra vedana* **(pain in bladder/testis/penile),** assessment of IIEF-15, assessment of Depression, assessment of anxietyandObjectiveparameters i.e Haematolagical test,  Biochemical test, Lipid profile, hormonal test etc.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Male
Target Recruitment
40
Inclusion Criteria
  • 1.Patients presenting with samanya of Klaibya.
  • 2.Patients having reduction of sexual desire.
  • 3.Unable to consummate the sexual act due to lack of erection, lack of rigidity at least 50 percent of coital instances.
  • 4.Ejaculation before, on or just after penetration or unable to achieve partner satisfaction.
  • 5.Patients willing to participate in the study.
Exclusion Criteria
  • Disorder of sexual organ e.g. Hypospadias, Vericocele.
  • Patients having any systemic disorders like Tuberculosis, Cancer, Cardiovascular disease, Diabetes Mellitus, Venereal disease, HIV, Hypertension and Spinal injuries etc.
  • Patients having drug induced and iatrogenic klaibya (erectile dysfunction) 4.
  • Erectile dysfunction due to nerve damage e.g. trauma, surgery.
  • 5.Patients suffering from severe depression and anxiety.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assessment of changes in specific symptoms of Klaibya and Erectile dysfunction.60 days for each patients.
Secondary Outcome Measures
NameTimeMethod
Changes in the objective parameters.60 days for each patients.

Trial Locations

Locations (1)

OPD and IPD of PG Department of Kayachikitsa. NIA Hospital.

🇮🇳

Jaipur, RAJASTHAN, India

OPD and IPD of PG Department of Kayachikitsa. NIA Hospital.
🇮🇳Jaipur, RAJASTHAN, India
Dr Binod Kumar Singh
Principal investigator
8448207879
drbinodbaghel@yahoo.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.